Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis

@article{Khler2017PeripheralAI,
  title={Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis},
  author={Cristiano Andr{\'e} K{\"o}hler and Thiago Holanda Freitas and Brendon Stubbs and Michael Maes and Marco Solmi and Nicola Veronese and Nayanna Quezado de Andrade and Gerwyn Morris and Brisa Fernandes and Andr{\'e} Russowsky Brunoni and Nathan Herrmann and Charles L. Raison and Brian J. Miller and Krista L. Lanct{\^o}t and Andr{\'e} Ferrer Carvalho},
  journal={Molecular Neurobiology},
  year={2017},
  volume={55},
  pages={4195-4206}
}
Mounting evidence suggests that aberrations in immune-inflammatory pathways contribute to the pathophysiology of major depressive disorder (MDD), and individuals with MDD may have elevated levels of predominantly pro-inflammatory cytokines and C-reactive protein. In addition, previous meta-analyses suggest that antidepressant drug treatment may decrease peripheral levels of interleukin-1 beta (IL-1β) and IL-6. Recently, several new studies examining the effect of antidepressants on these… Expand
Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis
TLDR
It is suggested that alterations in peripheral cytokine levels were associated with antidepressant treatment outcomes in MDD. Expand
The relationship between plasma cytokine levels and antidepressant response in patients with first-episode major depressive disorder.
TLDR
A range of cytokines were abnormal in patients with first-episode drug naïve MDD and most of the cytokines could be normalized after antidepressant treatment, and baseline ITAC level could be a predictive factor of antidepressant response. Expand
Cytokine Research in Depression: Principles, Challenges, and Open Questions
TLDR
Cytokines might not be associated with the diagnosis of depression according to the currently used diagnostic manuals, but rather with specific subtypes of depression, or with depressive symptoms across different psychiatric diagnoses, therefore the currently available diagnostic systems may not be the ideal starting point for psychiatric cytokine research. Expand
Prospective study on cytokine levels in medication-naïve adolescents with first-episode major depressive disorder.
TLDR
Level of cytokines before and after treatment for major depressive disorder in medication-naïve adolescents with first-episode MDD differed from those in healthy controls, and the levels of IL-2, IFN-γ, and IL-10 were altered after antidepressant treatment. Expand
Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder
TLDR
Measuring inflammatory markers and targeting inflammation or its downstream mediators may be relevant for depressed patients with multiple failed antidepressant treatment trials in their current depressive episode. Expand
Association of Chemokine (C-C Motif) Receptor 5 and Ligand 5 with Recovery from Major Depressive Disorder and Related Neurocognitive Impairment
TLDR
This is the first study providing valuable hints that both CCR5 and CCL5 might also serve as markers of therapy response prediction in MDD, and both levels were significantly decreased in the responder group compared to nonresponders even before treatment. Expand
Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression.
TLDR
Even within the same depressive states, MDD and BDD patients present different inflammatory features, particularly in regard to pro-inflammatory TNF-α and anti-inflammatory IL-13, and the fluctuations of cytokines induced by medication may provide a hint regarding the prediction of treatment response. Expand
Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD)
TLDR
Emergent evidence indicates that MDD is related to disturbed neurogenesis and suggests a possible role of neurotrophic factors in recovery of function in patients, and emerging data regarding the influence of different antidepressant drugs on a wide array of peripheral biomarkers such as interleukin (IL-1ß), IL-2, IL-5, ILs, or interferon (IFN)-γ are outlined. Expand
Differences in the immune-inflammatory profiles of unipolar and bipolar depression.
TLDR
Differences in immune profiles between BD and MDD patients exist, especially for the compensatory immune-regulatory system (CIRS): increased IL-10 is the primary immune- Regulatory mechanism in MDD, while increased sTNFR2 and KLOTHO are the primary regulatory mechanisms in BD. Expand
Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches.
TLDR
A narrative review of the available preclinical and clinical studies suggesting a role for the pro-inflammatory cytokine Macrophage migration inhibitory factor and the second member of the MIF family, D-dopachrome tautomerase, in the pathogenesis of Major Depressive Disorders (MDD). Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 72 REFERENCES
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
TLDR
Overall, while pharmacological antidepressant treatment reduced depressive symptoms, it did not reduce serum levels of TNFα, but antidepressant treatment did reduce levels of IL-1β and possibly those ofIL-6, which are consistent with the possibility that inflammatory cytokines contribute to depressive symptoms and that antidepressants block the effects ofinflammatory cytokines on the brain. Expand
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
TLDR
Overall, there were similarities in the pattern of cytokine alterations in schizophrenia, bipolar disorder and MDD during acute and chronic phases of illness, raising the possibility of common underlying pathways for immune dysfunction. Expand
Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder
TLDR
The results suggest that depressed patients only reach a partial reestablishment of HPA axis function after the long-term administration of SSRI. Expand
Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis
TLDR
There may be a normalization of overactive inflammatory processes following antidepressant treatment, according to a meta-analysis of studies which reported circulating levels of inflammatory markers before and after antidepressant treatment for people with depression. Expand
Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies
TLDR
This systematic review presents the existing early evidence which supports an association of many chemokines with the psychiatric disorders: depression, bipolar disorder, schizophrenia, mild cognitive impairment and Alzheimer's disease. Expand
Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system.
TLDR
The data suggest that lack of clinical therapeutic benefit of antidepressants is associated with overall activation of the inflammatory system. Expand
Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds.
TLDR
In accordance to early clinical response, duloxetine treatment could divide depressed patients into at least 2 subgroups characterized by clinical and laboratory differentiated behavior, suggesting different neurobiological background within depressive syndrome differentially sensitive to different drug components. Expand
Cumulative meta-analysis of interleukins 6 and 1 beta , tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder
Cumulative meta-analyses are used to evaluate the extent to which further studies are needed to confirm or refute a hypothesis. We used this approach to assess observational evidence on systemicExpand
Inflammation and clinical response to treatment in depression: A meta-analysis
TLDR
It is suggested that elevated levels of inflammation are contributory to treatment resistance, and targeting persistent inflammation in treatment-resistant depression may offer a potential target for the development of novel intervention strategies. Expand
The role of IL-2 and soluble IL-2R in depression and antidepressant response.
TLDR
There has been no consistent pattern in the associations observed between cytokine concentration, or changes thereof, and clinical indices of major depression and one intriguing question is whether pretreatment levels of immune system markers, such as IL-2R alpha, can be used to predict responses to antidepressant treatment. Expand
...
1
2
3
4
5
...